Two studies at Providence Cancer Center are focusing on patients’ genomes to help identify the most effective targeted anti-cancer therapies.
It has been a busy and exciting start to 2017 for immunotherapy researcher Eric Tran, Ph.D., and it could make a great difference in the lives of people fighting cancer.
More than 20 studies of promising new therapies for lung cancer patients are open now at Providence Cancer Center, including studies of targeted therapies and novel immunotherapy combinations.
Immunotherapy is a treatment approach that harnesses the immune system to recognize, attack and eliminate cancer.
The opportunity to conduct...
Patients with a variety of cancer types are eligible to receive new and promising treatments when they participate in Phase I research studies at Providence Cancer Center.
Providence Oral, Head and Neck Cancer Clinic offers world-class care for patients with benign and malignant tumors of the oral cavity (mouth), tongue, pharynx (throat), larynx (voice box), nose, paranasal sinuses, salivary glands and thyroid gland, as well as tumors at the skull base. Our medical and surgical oncology teams work collaboratively to start patients on treatment regimens very quickly.
The complex procedure, known as a “Jaw in a Day,” has been performed in only a few highly specialized centers in the world. Smith’s procedure, performed in August at Providence St. Vincent Medical Center, was the first on the West Coast.
Providence Cancer Center is actively involved in gastrointestinal cancer research, focusing our attention on cancers of the upper (esophagus and stomach), middle (pancreas, liver, gall bladder, bile ducts and small intestine) and lower (colon, rectum and anus) gastrointestinal tract.
Robert W. Franz, a supporter of cancer research at Providence and philanthropic leader here for more than 30 years, passed away Aug. 9 at Providence Portland Medical Center.
The Providence Thoracic Oncology Program emphasizes a multidisciplinary approach to cancer management. Our clinical trials program offers a broad array of innovative clinical research, including studies of new surgical techniques, radiation, chemotherapy, targeted therapy and immunotherapy agents, and tissue banking.